POMC and SATB2 associated disorder: From the results of our studies, IH upregulates the expression of POMC and CART mRNAs in neuronal cells and the expression of PYY, GLP-1, and NTS mRNAs in enteroendocrine cells, implying that IH itself may lead to loss of appetite in patients with SAS via the gut–brain axis (Figure 1).